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Background/Aims
Laryngopharyngeal symptoms of gastroesophageal reflux disease (GERD) such as globus sensation, hoarseness and chronic 
cough are becoming increasingly recognized. This study was aimed to investigate the diagnostic usefulness of combined dual 
channel multichannel intraluminal impedance (MII)/pH-metry in ‘off-proton pump inhibitor (PPI)’ patients with suspected lar-
yngopharyngeal reflux.
Methods
Ninety-eight patients with laryngopharyngeal symptoms of GERD were included. All patients were ‘off-PPI’ state for at least 2 
weeks prior to the study, and underwent endoscopy and dual channel combined MII/pH-metry.  
Results
The mean age of the patients was 49.8 ± 10.9 years and there were 44 males (44.9%). Fifty-three patients (54.1%) showed 
pathologic gastroesophageal reflux (GER). Combined dual channel MII/pH-metry achieved highest diagnostic yield of 49.0% 
and diagnostic yield of single channel combined MII/pH-metry was 37.8%. Addition of MII to standard pH-metry increased 
twofold of the diagnostic yield for detecting GER. Among 37 patients (37.8%) who had pathologic GER being detected by 
MII/pH-metry, 19 patients (19.4%) had nonacid GER (nonacid GER group) while 18 patients (18.4%) had acid GER (acid GER 
group). Pathologic GER group, as classified by MII/pH-metry showed more frequent globus sensation than nonpathologic GER 
group. Acid GER group had more proximal reflux than nonacid GER group, especially in the upright position.
Conclusions
In this study, combined dual channel MII/pH-metry showed the highest diagnostic yield for detecting GER. This technique can 
be performed primarily to accurately diagnose laryngopharyngeal reflux disease and exclude other causes of laryngopharyngeal 
symptoms.
(J Neurogastroenterol Motil 2010;16:157-165)
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Introduction
Gastroesophageal reflux disesase (GERD), defined as a con-
dition developing by the reflux of stomach contents to cause trou-
blesome symptoms and/or complications, is a common chronic 
disorder of our time, affecting about 10% to 20% of the adult 
population in Western world.
1,2 In Asian countries, the preva-
lence of GERD varies from 2.5% to 6.2%, and it has shown to in-
crease over the last two decades.
3,4 Typically, heartburn and re-
gurgitation are well-known common presenting symptoms of 
GERD. However, extraesophageal symptoms of GERD such as 
globus sensation, hoarseness, and chronic cough are becoming 
increasingly recognized.
5,6 The prospective ProGERD study 
from Europe involving 6,215 patients with heartburn has found 
extraesophageal symptoms in 32.8% of patients, and Richter et 
al.
7 recently reported that 80% of patients with weekly heartburn 
had at least one extraesophageal manifestation, compared to 49% 
of those without heartburn.
6 Many of the atypical GERD symp-
toms are nonspecific and often subjective, and can be caused by 
several other conditions like smoking, allergies, neurogenic, and 
psychogenic disorders
8 which make diagnosing extraesophageal 
GERD difficult. Moreover, the relationship between GERD 
and extraesophageal symptoms is frequently problematic to es-
tablish with a high degree of certainty. At present, the sig-
nificance of diagnosis and treatment of extraesophageal GERD is 
still controversial.
9-11 Therapeutic trial of a proton pump inhibitor 
(PPI) in double standard dose for 3 to 4 months has been sug-
gested as a first step management in patients with suspected ex-
traesophageal manifestations of GERD.
9 However, some pa-
tients failed to respond to the PPI treatment and there were stud-
ies reporting that up to 50% of these patients responded to 
placebo.
12-14 These findings raise the question of whether the ex-
traesophageal symptoms are true manifestations of gastro-
esophageal reflux (GER). For this reason, there was a suggestion 
that objective examination to demonstrate the proximal reflux 
should precede empirical PPI treatment.
15,16 Traditionally, 
24-hour ambulatory pH monitoring was recognized as standard 
diagnostic test for GERD. However, multichannel intraluminal 
impedance (MII) combined with pH monitoring is now consid-
ered the most sensitive tool for diagnosis and characterization of 
GERD, and this new technology allows detection of both acid 
and nonacid GER and also makes it possible to assess the nature 
(liquid, gas, or mixed liquid-gas) of refluxate and proximal extent 
of GER. 
This study was aimed to investigate the diagnostic usefulness 
of combined dual channel MII/pH-metry in ‘off-PPI’ patients 
with suspected laryngopharyngeal manifestations of GERD. 
Materials and Methods
1. Subjects
We performed a prospective cross-sectional study of 98 pa-
tients with laryngopharyngeal manifestations of GERD, such as 
globus sensation, hoarseness, and chronic cough who admitted to 
Pusan National University Hospital from June 2006 to March 
2009. Patients were included in a consecutive manner. Patients 
with a history of any esophageal or gastric surgery were not 
included. All subjects were ‘off-PPI’ state for at least 2 weeks pri-
or to the study and had undergone both the esophagogas-
troduodenoscopy and combined dual channel MII/pH-metry af-
ter at least 8 hours of fasting. Esophageal manometry was also 
performed to identify the level of the low esophageal sphincter 
(LES) and to rule out any functional esophageal disorders. 
2. Symptom assessments
Laryngopharyngeal symptoms were evaluated by patient in-
terview and each symptoms were scored as below by the reference 
to GERD-Health Related Quality of Life scale: (0) no symp-
toms; (1) symptoms noticeable, but not bothersome; (2) symp-
toms noticeable and bothersome, but not everyday; (3) symptoms 
bothersome everyday; (4) symptoms that affect daily activities; 
and (5) symptoms are incapacitating. Predominant symptom was 
defined as having the highest score. Combined typical reflux 
symptom was defined as heartburn or regurgitation to be present 
at a frequency of ≥ 1/wk. 
3. Esophagogastroduodenoscopy
Absence or presence of erosive esophagitis (EE) and atrophic 
gastritis were examined by esophagogastroduodenoscopy. Fur-
thermore, reflux esophagitis was graded from A to D using Los 
Angeles classification,
17 and atrophic gastritis was divided into a 
closed-type and an open-type by Kimura-Takemoto endoscopic 
classification.
18,19 Gastroesophageal flap valve (GEFV) was also 
evaluated and was graded I to IV according to the recently de-
scribed grading by Hill et al.
20 The GEFV was largely classified 
into 2 groups: the normal GEFV group (grades I and II) and the 
abnormal GEFV group (grades III and IV).
21 Dual Channel MII/pH-metry for LPRD 
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Table 1. Patients’ Characteristics
Total (N = 98)
Age [mean ± SD, yr]   49.8 ± 10.9
Male [n (%)] 44 (44.9)
Body mass index [mean ± SD, kg/m
2] 23.3 ± 2.9
Smoking [n (%)] 15 (15.3)
Alcohol use [n (%)] 38 (38.8)
Duration of symptoms 
   ＜ 1 mo [n (%)] 1 (1.0)
   ＜ 3 mo [n (%)] 18 (18.4)
   ＜ 1 yr [n (%)] 33 (33.7)
   ≥ 1 yr [n (%)] 46 (46.9)
Predominant symptoms
   Globus sensation [n (%)] 77 (78.6)
   Hoarseness [n (%)] 15 (15.3)
   Cough [n (%)] 6 (6.1)
   Globus sensation + hoarseness [n (%)] 2 (2.0)
Combined typical symptoms [n (%)] 51 (52.0)
Endoscopic erosive esophagitis [n (%)] 11 (11.2)
Endoscopic atrophic gastritis
   Absent [n (%)] 29 (29.6)
   Closed type [n (%)] 46 (46.9)
   Open type [n (%)] 23 (23.5)
Abnormal gastroesophageal flap valve  14 (14.3)
 (Hill grade III or IV) [n (%)]
4. Combined dual channel pH-Metry/MII monitoring 
The dual channel pH-metry/MII catheter consists of a 2.3 
mm polyurethane catheter incorporating 6 impedance segments 
(each segment 2 cm long) and 2 pH-measuring electrodes 
(Sandhill Scientific Inc., Denver, CO, USA). The configuration 
of this catheter allowed recording the changes in intraluminal im-
pedance at 3, 5, 7, 9, 15, and 17 cm above the LES. In addition, 
pH was monitored at 5 cm above the LES (distal) and 20 cm 
above the LES (proximal). After defining the LES by using con-
ventional manometry, dual channel pH-metry/MII catheter was 
inserted transnasally and distal pH probe was positioned 5 cm 
above the LES. Data from the impedance channels and the pH 
electrodes were transmitted at a frequency of 50 Hz and stored on 
a portable data recorder (Sleuth, Sandhill Scientific Inc., High-
lands Ranch, CO, USA). After 24-hour recording, data were up-
loaded on a personal computer and analyzed by using a commer-
cially available software system (Bioview Analysis, Sandhill 
Scientific Inc., Highlands Ranch, CO, USA). During the re-
cording period, patients were encouraged to follow a regular ac-
tivity and meal regimens, and were given a personal diary to note 
meal times, time in the recumbent position, and the timing of any 
GERD-related symptoms.
5. Analyzing pH data
Acid reflux episode was defined as a drop in pH to less than 4 
for at least 5 seconds. Total acid exposure time (%) was calculated 
as the total time of acid reflux episodes divided by the time of 
monitoring. DeMeester score,
22 which has been widely used to 
evaluate acid reflux, was obtained using 6 different parameters: 
(1) total percentage time pH ＜ 4.0, (2) percentage time pH ＜ 
4.0 in the upright period, (3) percentage time pH ＜ 4.0 in the 
recumbent period, (4) the total number of acid reflux episodes, 
(5) the total number of acid reflux episodes longer than 5 mi-
nutes, and (6) the duration of the longest acid reflux episodes.   
6. Analyzing MII data 
The meal periods were excluded from the analysis. Liquid re-
flux episode was defined as a fall in impedance of ≥ 50% of base-
line which moved in retrograde direction on the 2 distal im-
pedance sites. Gas reflux episode was defined as a rapid (3 kΩ/ 
sec) increase in impedance ＞ 5,000 Ω, occurring simultaneously 
in at least 2 esophageal impedance-measuring segments, in the 
absence of swallowing. Mixed liquid-gas reflux episode was de-
fined as gas reflux occurring immediately before or during a liq-
uid reflux. These reflux episodes were classified as acidic if the 
pH dropped below 4 or as non-acidic if the pH remained above 4 
during the episode. Proximal reflux episode was considered when 
the refluxate reached the 15 cm impedance sensor. Total bolus 
exposure time (%) was defined as the sum of bolus clearance time 
of all individual reflux episodes divided by the time of moni-
toring. Bolus clearance time was defined as the time from a drop 
in impedance to 50 % of its baseline value to recovery to 50 % of 
baseline value in the most distal impedance channel. 
7. Interpretating combined dual channel pH-metry/MII 
data
Total acid exposure time (%) of distal pH probe ＞ 4.0 or 
DeMeester score ＞ 14.7 was considered as an acid GER. Total 
bolus exposure time (%) more than 1.4 without acid GER was 
considered as a nonacid GER. Acid gastropharyngeal reflux was 
defined by proximal pH probe when at least one of the following 
criteria was met
23,24: (1) total acid exposure time (%) ＞ 0.1%, (2) 
acid exposure time (%) in upright position ＞ 0.2%, (3) acid ex-
posure time (%) in supine position ＞ 0.0%, and (4) acid reflux 
number ≥ 4Bong Eun Lee, et al
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Figure 1. Diagnostic yield of various 
methods for detecting gastroesopha-
geal reflux. Diagnostic yield of pro-
ximal pH-metry, endoscopy, distal 
pH-metry, multichannel intraluminal 
impedance (MII) testing, MII/distal 
pH-metry, and dual channel MII/pH- 
metry was 20.4%, 11.2%, 18.4%, 
33.7%, 37.8%, and 49.0%, respecti-
vely. Pathologic proximal acid reflux 
was seen in 10 patients without any 
evidence of distal gastroesophageal 
reflux (GER), and erosive esophagitis 
(EE) occured as a single phenomenon 
in 5 patients. Four patients with 
negative result on MII testing had 
pathologic acid GER, and 19 patients 
with negative result on distal pH-metry 
had abnormal finding with MII testing.
8. Statistical methods
All continuous variables were presented as mean ± standard 
deviation, and the proportions were expressed as numbers (%). 
Mann-Whitney U test and Kruskal-Wallis test were used when 
comparing continuous parameters, and the proportions were 
compared using the chi-square test. The computer software used 
for statistical analysis was SPSS (version 12.0, SPSS Inc., 
Chicago, IL, USA). A p-value of ＜ 0.05 was considered statisti-
cally significant.  
Results
A total of 98 patients were included in this study. The dual 
pH-impedance probe was well tolerated for all patients. The total 
recording time was 21.6 hours, and meal periods were excluded 
from the analysis. 
Table 1 summarizes the characteristics of enrolled patients. 
The mean age of the patients was 49.8 ± 10.9 years (range 
21-71). There were 44 males (44.9%) and the mean body mass 
index was 23.3 ± 2.9 kg/m
2 (range 15.8-30.5). Fifteen patients 
(15.3%) were smokers and 38 patients (38.8%) were alcohol 
users. Only 1 patient (1.0%) had ＜ 1 month of symptom, and 46 
patients (46.9%) had ≥ 1 year of symptom. Ninety-six patients 
(98.0%) had 1 predominant symptom, and the most common 
presenting symptom was globus sensation (n = 77, 78.6%) fol-
lowed by hoarseness (n = 15, 15.3%) and chronic cough (n = 6, 
6.1%). Two patients (2.0%) complained same degree of globus 
sensation and hoarseness. Fifty-one patients (52.0%) complained 
of coexisting typical reflux symptoms such as heartburn and 
regurgitation. EE were seen in 11 patients (11.2%), and all these 
patients were Los Angeles grade A. Sixty-nine patients (70.4%) 
had endoscopic atrophic gastritis: closed-type in 47 cases (48.0%) 
a n d  o p e n - t y p e  i n  2 2  c a s e s  ( 2 2 . 4 % ) .  A b n o r m a l  G E F V  ( H i l l  
grades III or IV) were seen in 14 patients (14.3%).
Figure 1 shows the diagnostic yield of various methods for 
detecting GER. Of a total 98 patients, 53 patients showed patho-
logic GER (54.1%) with at least one abnormal result in either en-
doscopy, proximal pH-metry, distal pH-metry, or MII. Patho-
logic proximal acid reflux was seen in 10 patients without any evi-
dence of distal GER, and EE occured as a single phenomenon in 
5 patients. Four patients with negative result in MII testing had 
pathologic acid GER, and 19 patients with negative result on dis-
tal pH-metry had abnormal finding in MII testing. Diagnostic 
yield of single channel combined MII/pH-metry and dual chan-
nel combined MII/pH-metry was 37.8% and 49.0%, respec-
tively. Among 37 patients (37.8%) who had pathologic GER de-
tected by MII/pH-metry, 19 patients (19.4%) had nonacid GER 
(nonacid GER group) and 18 patients (18.4%) had acid GER 
(acid GER group) (Fig. 2).Dual Channel MII/pH-metry for LPRD 
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Table 2. Comparison of Clinical Characteristics Between Nonpathologic Gastroesophageal Reflux [GER (-)] and Pathologic 
Gastroesophageal Reflux [GER (+)] Group
GER (-) group  GER (+) group 
                                                   p-value
(n = 61, 62.2%) (n = 37, 37.8%)
Age [mean ± SD, yr]   48.9 ± 11.1   51.2 ± 10.7 0.236
Male [n (%)] 26 (42.6) 18 (48.6) 0.561
Body mass index [mean ± SD, kg/m
2] 23.1 ± 1.7 23.6 ± 3.2 0.437
Smoking [n (%)]   9 (14.8)   6 (16.2) 0.845
Alcohol use [n (%)] 28 (46.7) 10 (27.0) 0.054
Duration of symptoms ≥ 1 yr [n (%)] 27 (44.3) 19 (51.4) 0.495
Predominant symptoms 0.046
  Globus sensation [n (%)] 44 (72.1) 33 (89.2)
Other symptoms [n (%)] 17 (27.9)   4 (10.8)
Combined typical symptoms [n (%)] 33 (54.1) 18 (48.6) 0.601
Endoscopic erosive esophagitis [n (%)] 6 (9.8)   5 (13.5) 0.402
Endoscopic atrophic gastritis 0.065
Absent or closed type [n (%)] 51 (83.6) 24 (64.9)
Open type [n (%)] 10 (16.4) 13 (35.1)
Abnormal GEFV (Hill grade III or IV) [n (%)]   9 (14.8)   5 (13.5) 0.865
GEFV, gastroesophageal flap valve.
Bold style indicates statistical significance.
Figure 2. Multichannel intraluminal impedance/pH-metry results.
On comparing the data between nonpathologic GER [GER 
(-)] and pathologic GER [GER (+)] group (Table 2), as classi-
fied by MII/pH-metry, we did not find any inter-group demo-
graphic differences. Globus sensation was observed more fre-
quently in GER (+) group than in GER (-) group with statisti-
cally significant difference (89.2% vs. 72.1%, p = 0.046). 
Endoscopic findings did not show differences between these 2 
groups. 
There were no significant differences in patients’ character-
istics and endoscopic findings between acid and nonacid GER 
group. We further analyzed and compared the results of im-
pedence test between these 2 groups (Table 4). No differences 
were seen in bolus exposure time, mean bolus clearance time, lon-
gest bolus exposure time and reflux number. However, acid 
GER group had more proximal reflux episodes than nonacid 
GER group (37.6 ± 17.7 vs. 21.7 ± 11.2, p = 0.003), especially 
in the upright position (32.7 ± 18.0 vs. 19.4 ± 9.5, p = 0.009).
Discussion
The superiority of combined MII/pH-metry compared with 
pH-metry in the diagnosis of GERD is already proven and this 
method is being regarded as the best tool for assessing patients 
with suspected GERD. However, previously published data 
about combined MII/pH-metry are mostly based on patients 
with typical GERD symptoms or on patients who were under 
acid suppressive therapy.
25-27 In 2007, Bajbouj et al.
28 firstly in-
vestigated the utility of MII/pH-metry in ‘off-PPI’ patients with 
atypical symptoms. They reported that 63.4% of patients suffer-
ing from atypical symptoms had pathologic GER and 61% of pa-
tients were diagnosed with GERD by MII/pH-metry. With 
these results, they suggested combined MII/pH-metry to be es-
sential in the diagnostic work-up of patients with atypical 
GERD. Malhotra et al.
29 evaluated patients with suspected ex-
traesophageal GERD who were on or off PPI therapy, and con-
cluded MII/pH-metry to be useful in ruling out GERD and re-
directing the management in these patients. In our study, we 
aimed not only to investigate the diagnostic usefulness of com-Bong Eun Lee, et al
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Table 3. Comparison of Clinical Characteristics Between Acid Gastroesophageal Reflux and Nonacid Gastroesophageal Reflux Group 
Acid GER group  Nonacid GER group
                                                      p-value
(n = 18, 48.6%) (n = 19, 51.4%)
Age [mean ± SD, yr] 47.8 ± 12.8 54.5 ± 7.1 0.128
Male [n (%)]   8 (44.4) 10 (54.6) 0.618
Body mass index [mean ± SD, kg/m
2] 22.7 ± 3.4 24.4 ± 2.8 0.129
Smoking [n (%)]   4 (22.2)   2 (10.5) 0.303
Alcohol use [n (%)]   5 (27.8)   5 (26.3) 0.605
Duration of symptoms ≥ 1 yr [n (%)] 12 (66.7)   7 (36.8) 0.070
Predominant symptoms 0.039
Globus sensation [n (%)]   18 (100.0) 15 (78.9)
Other symptoms [n (%)] 0 (0.0)   4 (21.1)
Combined typical symptoms [n (%)]   9 (50.0)   9 (47.4) 0.873
Endoscopic reflux esophagitis [n (%)]   2 (11.1)   3 (15.8) 0.527
Endoscopic atrophic gastritis  0.548
Absent or closed type [n (%)] 12 (66.6) 12 (63.2)
Open type [n (%)]   6 (33.4)   7 (36.8)
Abnormal GEFV (Hill grade III or IV) [n (%)]   3 (16.7)   2 (10.5) 0.473
GER, gastroesophageal reflux; GEFV, gastroesophageal flap valve.
Bold style indicates statistical significance.
Table 4. Comparison of Intraluminal Impedance Results Between Acid Gastroesophageal Reflux and Nonacid Gastroesophageal Reflux 
Group
Acid GER group  Nonacid GER group 
MII results                                      p-value
(n = 18, 48.6%) (n = 19, 51.4%)
Total bolus exposure time [mean ± SD, %]   3.1 ± 2.3   4.3 ± 7.2 0.637
BET in the supine position    0.7 ± 1.1   0.9 ± 1.8 0.901
BET in the upright position    4.9 ± 2.8     7.8 ± 10.4 0.693
Mean bolus clearance time [mean ± SD, sec] 16.3 ± 5.8 14.2 ± 6.6 0.211
MBCT in the supine position    10.1 ± 12.2  145.7 ±588.6 0.445
MBCT in the upright position    19.5 ± 12.7 15.2 ± 6.8 0.368
Longest bolus exposure time [mean ± SD, sec]   8.86 ± 10.4     47.5 ± 108.5 0.114
LBET in the supine position    2.3 ± 4.6   4.1 ± 9.8 0.480
LBET in the upright position     7.8 ± 10.2     44.7 ± 109.2 0.346
Total reflux number [mean ± SD, n]   69.4 ± 35.3   52.8 ± 17.5 0.125
Reflux number in the supine position    11.4 ± 12.6   6.0 ± 6.7 0.234
Reflux number in the upright position    58.0 ± 31.4   46.8 ± 24.3 0.338
Total liquid ± mixed reflux number [mean ± SD, n]   55.6 ± 29.8   41.4 ± 21.3 0.162
Liquid ± mixed reflux number in the supine position   8.8 ± 8.9   5.3 ± 6.5 0.264
Liquid ± mixed reflux number in the upright position   46.7 ± 27.1   36.1 ± 18.2 0.287
Total proximal reflux number [mean ± SD, n]   37.6 ± 17.7   21.7 ± 11.2 0.003
Total proximal reflux number in the supine position    4.9 ± 5.5   2.3 ± 2.7 0.161
Total proximal reflux number in the upright position    32.7 ± 18.0  19.4 ± 9.5 0.009
Total postprandial reflux number [mean ± SD, n]   37.9 ± 24.7    32.8 ± 15.0 0.438
MII, intraluminal impedance; GER, gastroesophageal reflux; BET, bolus exposure time; MBCT, mean bolus clearance time; LBET, longest bolus exposure time.
Bold style indicates statistical significance.
bined dual channel pH-Metry/MII monitoring in ‘off-PPI’ pa-
tients with suspected laryngopharyngeal manifestations of 
GERD, but to compare clinical characteristics and diagnostic da-
ta between pathologic GER and nonpatholgic GER group as 
well as between acid and nonacid GER group. Fifty-three pa-
tients (54.1%) had pathologic GER and the diagnostic yield of Dual Channel MII/pH-metry for LPRD 
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combined MII/pH-metry was 37.8%, which was lower than that 
of previous study by Bajbouj et al. Lower prevalence of GERD 
in Korea than in Western countries and different manner for in-
terpretating pH/impedance data seemed to be the reasons for 
such different outcomes. Addition of MII to standard pH-metry 
increased the diagnostic yield for detecting GER around two fold 
in patients with laryngopharyngeal symptoms, which might be 
mostly due to the detection of nonacidic reflux. And dual channel 
combined MII/pH-metry showed 49.0% of diagnostic yield, 
which was the most sensitive method for diagnosing GER. The 
diagnostic yield of proximal pH-metry alone was 20.8%, and 10 
patients (18.9% of patients with pathologic GER) showed patho-
logic proximal acid reflux without any evidence of distal GER. 
This ironic finding might have been caused by the current defi-
nitions of acid GER and GER which are not linked to each other. 
Also the lack of agreement of normative values and methodologic 
variability in proximal esophageal pH measurement, especially 
relating to the positioning of the upper pH probe make inter-
pretation of proximal pH data difficult.
30 More importantly, 
proximal pH-metry cannot detect nonacid GER and cannot pro-
vide any information on causality between refluxed gastric acid 
and symptoms.
31 Because of low reproducibility and sensitivity, 
the clinical utility of proximal pH monitoring remains unproven.
32 
As of today, careful interpretation of proximal pH data in consid-
eration of clinical factors is needed until more sensitive and accu-
rate techniques for defining proximal reflux develp. 
After all, 45.9% of enrolled patients had negative result from 
all methods for detecting GER, and this finding seems very im-
portant in the overall management of these patients. This result 
makes it reasonable that objective examination to demonstrate 
pathologic GER precedes empirical PPI therapy to exclude other 
causes of atypical symptoms and to avoid unnecessary medication 
including PPI. Based on the current study, combined dual chan-
nel MII/pH-metry can provide proper information for manage-
ment in patients with suspected laryngopharyngeal manifes-
tations of GERD.
In general, nonerosive reflux disease patients are known to 
have lower esophageal acid exposure than patients with EE and 
Barrett’s esophagus. Recently, Savarino et al.
33 compared reflux 
episodes and symptom association in nonerosive reflux disease 
and EE patients using combined MII/pH-metry, and they re-
ported that acid reflux episodes, volume, and acid clearance were 
important factors in the pathogenesis of reflux induced lesions. 
However, there was a notable result in our study that 6 patients 
(11.3% of patients with pathologic GER) with negative outcome 
on MII/pH-metry presented with endoscopic EE. What would 
be the reasons for such outcome? Actually, normal reference val-
ues for MII/pH-metry among racial groups are not presently 
available and there are few reports about MII/pH-metry in 
Korea. Although subjects in this study were Koreans, we had no 
option but to refer to several western works as a guide. Usually, 
Asians are known to have smaller parietal cell mass and lower acid 
output compared to whites.
34 And one muticenter study about 
normal ambulatory 24-hour esophageal pH values in Koreans 
suggested 3.8 as a cutoff value for total acid exposure time (%) 
compared to about 4 in Western studies.
35 This unmatched anal-
ysis seems one of the reasons for MII/pH-metry negative EE 
patinets. The fact that the degree of esophageal mucosal defense 
and repairment to gastric contents is individually variable could 
explain for MII/pH-metry negative EE patients. 
Unlike other studies about MII/pH-metry, we investigated 
endoscopic EE, atrophic gastritis and GEFV to evaluate their re-
lationship with laryngopharyngeal reflux. Previously, we have 
studied 608 patients referred to our motility laboratory and found 
abnormal GEFV to be associated with GER, and the degree of 
atrophic gastritis to inversely relate with GER.
36 According to the 
previous data, we expected similar outcome in present study, such 
as nonacid GER being related with open-type atrophic gastritis. 
But, we could not find significant association between endoscopic 
findings and GER. There is about 2 possible factors related with 
such outcomes. Firstly, definition of GER differed from previous 
study. Previous study defined GER by means of pH-metry or 
endoscopy, whereas present study used MII/pH-metry to eval-
uate GER. Secondly, GER include both reflux of gastric con-
tents and duodenal contents. Therefore, nonacid GER group 
may be related with not only nonacidic gastric content due to hy-
pochlohydria associated with atrophic gastritis but also post-
prandial neutralized gastric content and duodenogastroesophag-
eal reluxate.
We observed globus sensation to be more related with patho-
logic GER than other laryngopharyngeal symptoms and 55% of 
patients with globus sensation and concomitant pathologic GER 
were in acid GER group. Anandasabapathy et al.
25 reported that 
acid reflux was infrequent in patients with globus sensation and 
nonacid reflux might be predictive of the GERD-globus corre-
lation. But their study was designed with patients with globus 
sensation on PPI therapy, so this might have made a difference. 
The diagnostic utility of MII/pH-metry has been proven in 
extraesophageal as well as typical GERD at several works includ-
ing our study. Most studies defined GERD using symptom in-Bong Eun Lee, et al
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dex or symptom association probability. Of course, it is important 
to evaluate whether or not the symptoms are caused by reflux. 
However, atypical symptoms usually persist continuously and do 
not have a sudden onset that could be easily recognized by the 
patient.
28,37 This characteristic makes it difficult to mark an reflux 
event at a single timepoint while the difficulty on assessment of 
symptom index in patients with atypical symptoms makes the di-
agnosis of extraesophageal GERD more confusing than typical 
GERD.
In conclusion, we confirmed the diagnostic usefulness of dual 
channel combined MII/pH-metry in patients with suspected lar-
yngopharyngeal manifestations of GERD. Further large-scale 
population based study to provide normal values of dual channel 
MII/pH-metry in Koreans is required and more accurate meth-
od to prove the causal link between pathologic GER and lar-
yngopharyngeal symptoms other than symptom index or symp-
tom association probability should be developed. Combination of 
PPI trial with dual channel MII/pH-metry will make the lar-
yngopharyngeal manifestations of GERD more distinct. 
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